PRPO
Precipio, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$23.40-5.03%
Price as of Jul 20, 2026
PRPO profitability
Precipio, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 43.3%
- EBITDA margin
- 3.3%
- EBIT margin
- -6.8%
- Net margin
- -3.5%
- Free cash flow margin
- 2.1%
Returns
- Return on equity
- -6.5%
- Return on assets
- -4.4%
- Return on invested capital
- -10.0%
- Asset turnover
- 1.24x
Cash efficiency
- Cash from operations
- $793.0K
- Cash per share
- $1.46
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.